Moreover, in PD patients with a mutation in the LRRK2 gene, a higher level of inflammatory proteins in blood was associated with a clinical subtype characterized by a more severe and broad spectrum of motor and non-motor symptoms [11]. This evidence concerns the gene PROS1 and Parkinson disease.